During the past decade, Arizona Oncology Associates- Biltmore Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Oncology Associates- Biltmore Cancer Center" #1 sponsor was "Agenus Inc." with 1 trials, followed by "GOG Foundation" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology Associates- Biltmore Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Oncology Associates- Biltmore Cancer Center" are "Breast Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Adenosquamous Carcinoma" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Arizona Oncology Associates- Biltmore Cancer Center" in a lesser frequency.

Most popular intervention types in "Arizona Oncology Associates- Biltmore Cancer Center" are "Drug" (9 trials), "Other" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (6 trials), "Carboplatin" (3 trials), "Cyclophosphamide" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Oncology Associates- Biltmore Cancer Center" are 6 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Arizona Oncology Associates- Biltmore Cancer Center". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Arizona Oncology Associates- Biltmore Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Oncology Associates- Biltmore Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".